Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Psyence Biomedical Ltd.

    NASDAQ: PBM · Real-Time Price · USD
    4.80
    -0.42 (-8.05%)
    At close: Jun 11, 2025, 3:59 PM
    5.10
    6.25%
    After-hours: Jun 11, 2025, 07:25 PM EDT

    Psyence Biomedical Statistics

    Share Statistics

    Psyence Biomedical has 583.26K shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 583.26K

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 225

    FTD / Avg. Volume

    n/a
    		 0.26%

    Short Selling Information

    The latest short interest is 34.04K, so 5.84% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 34.04K

    Short % of Shares Out

    n/a
    		 5.84%

    Short % of Float

    n/a
    		 5.92%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -76.24 and the forward PE ratio is null. Psyence Biomedical's PEG ratio is -0.07.

    PE Ratio

    n/a
    		 -76.24

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -355.48

    P/FCF Ratio

    n/a
    		 -1321.73

    PEG Ratio

    n/a
    		 -0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Psyence Biomedical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.09, with a Debt / Equity ratio of -0.95.

    Current Ratio

    n/a
    		 0.09

    Quick Ratio

    n/a
    		 0.09

    Debt / Equity

    n/a
    		 -0.95

    Debt / EBITDA

    n/a
    		 -3.8

    Debt / FCF

    n/a
    		 -3.54

    Interest Coverage

    n/a
    		 -51.98

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-5,115,904.8

    Employee Count

    n/a
    		 10

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -98.59% in the last 52 weeks. The beta is 0.15, so Psyence Biomedical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.15

    52-Week Price Change

    n/a
    		 -98.59%

    50-Day Moving Average

    n/a
    		 4.11

    200-Day Moving Average

    n/a
    		 29.8

    Relative Strength Index (RSI)

    n/a
    		 52.33

    Average Volume (20 Days)

    n/a
    		 85,368

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -240

    Operating Income

    n/a
    		 -2.75M

    Net Income

    n/a
    		 -51.16M

    EBITDA

    n/a
    		 -2.75M

    EBIT

    n/a
    		 -51.11M

    Earnings Per Share (EPS)

    n/a
    		 -7.85
    Full Income Statement

    Balance Sheet

    The company has 762.8K in cash and 10.45M in debt, giving a net cash position of -9.69M.

    Cash & Cash Equivalents

    n/a
    		 762.8K

    Total Debt

    n/a
    		 10.45M

    Net Cash

    n/a
    		 -9.69M

    Retained Earnings

    n/a
    		 -57.46M

    Total Assets

    n/a
    		 2.25M

    Working Capital

    n/a
    		 -1.27M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -2.95M and capital expenditures -5.73K, giving a free cash flow of -2.95M.

    Operating Cash Flow

    n/a
    		 -2.95M

    Capital Expenditures

    n/a
    		 -5.73K

    Free Cash Flow

    n/a
    		 -2.95M

    FCF Per Share

    n/a
    		 -0.45
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PBM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for PBM.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 5, 2025. It was a backward split with a ratio of 1:8.

    Last Split Date

    n/a
    		 May 5, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:8

    Scores

    Altman Z-Score

    n/a
    		 -36.29

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist